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A sensitive, reliable and accurate high-performance liquid chromatography (HPLC) method coupled with 
photodiode array detector (DAD) were developed for the simultaneous quantitative determination of 
aconitine, mesaconitine and hypaconitine in rat plasma and urine by optimizing the extraction, 
separation and analytical conditions. The analyses were chromatographed on a ZORBAX Eclipse 
XDB-C18 column (150 mm × 4.6 mm i.d.; 5 µm particle size) with gradient elution using solvents of 
acetonitrile and ammonium acetate buffer (pH 10.0). The detection wavelength was 240 nm. Intra-assay 
and inter-assay precision of the analyses were less than 10% and the average recovery rates obtained 
were in the range of 85.63 - 90.94% for all analysis of the three aconitum alkaloids with relative standard 
deviations (RSD) below 14%. Positive linear relationships were observed in correlation coefficients that 
exceeded 0.95. The limits of detection (signal-to-noise ratio of 3) were 2.64, 1.58 and 2.75 ng for 
aconitine, mesaconitine and hypaconitine, respectively. The method can provide a scientific and 
technical platform to determine the concentration of aconitum alkaloids in plasma during a pilot 
pharmacokinetic study in rats.  
 





Aconitine, mesaconitine and hypaconitine (Figure 1) are 
three kinds of highly toxic diester-diterpene Aconitum 
alkaloids, which mainly originated from Chinese medicinal 
herbs of the genus Aconitum in the family of Ranuncucaceae, 
known as Fuzi (Radix Aconiti Lateralis) or Chuanwu 
(Radix Aconiti Kusnezoffii). Toxicological studies demon- 
strated that the lethal dose 50% (LD50) of aconitine, 
mesaconitine and hypaconitine orally in mice is 1.8, 1.9 
and 5.8 mg/kg, respectively (Zhou, 1983). The lethal dose 
of these alkaloids in humans is estimated to be 2.5 mg (Li 
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they are widely used to treat joint pain, arthritic and 
rheumatic diseases for over 2,000 years by Chinese 
doctors. These diester-type alkaloids also have excellent 
pharmacological effect, such as anti-inflammatory and 
antinociceptive properties (Ameri, 1998). At present, 
research works on diester-diterpene Aconitum alkaloids is 
focused on the identification of their poisoning and toxic 
dose (Zhang et al., 2005). Due to the rapid metabolism of 
diester-diterpene Aconitum alkaloids in vivo, the 
identification of Aconitum alkaloids poisoning and the 
safety research in pharmacology are difficult. Therefore, a 
simple and reliable determination method of Aconitum 
alkaloids in biological fluid is essential in the field of 
toxicology, pharmacology and forensic medicine.  
Several methods have been reported for detecting 
aconitine, mesaconitine and hypaconitine, including high- 
performance liquid chromatography (HPLC) (Wang et al., 
2004; Jiang et al., 2005; Wang et al., 2006; Liu and Chao, 
2006), liquid chromatography-mass spectrometry 
(LC-MS) (Ohta et al., 1997; Wang et al., 2001; Kaneko et 
al., 2006; Zhang et al., 2005), capillary electrophoresis 
(CE) (Guo et al., 2004; Feng and Li 2002), capillary 
electrophoresis-mass spectrometry (CE-MS) (Feng et al., 
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Aconitine              C2H5         OH
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2003), gas chromatography-mass spectrometry (GC-MS) 
(Ito et al., 1998) and so forth.  
In the current study, we investigated the effect of 
different alkaline buffer concentrations and pH values and 
successfully developed a modified HPLC analytical 
method for the simultaneous quantitative determination of 
the three diester-diterpene Aconitum alkaloids in rat plasma 
and urine. Furthermore, we investigated the extraction 
methods, peak confirmation, mobile phase buffer and 
gradient elution program according to the complexity of 
biological samples.  
 
 
MATERIALS AND METHODS 
 
Chemical and reagents  
 
Acetonitrile was of HPLC grade (Sigma-Aldrich, Germany). Solid 
phase extraction (SPE) columns (Oasis® MCX) were obtained from 
Waters (Milford, USA). All other chemicals used were of analytical 
reagent grade and were charged from Beihua Fine Chemicals Co., 
Ltd (Beijing, China). Deionized water was prepared using a Millipore 
(Billerica, MA, USA) water purification system. All solvents and 
solutions were filtered through a Millipore filter (0.45 µm) before 
using.  
Reference standards of aconitine, mesaconitine and hypaconitine 
were purchased from the National Institute for the Control of 
Pharmaceutical and Biological Products in China. Their chemical 
structures were further identified by LC-MS in our laboratory.  
Drug-free urine and heparinized plasma were obtained from 
different young, healthy male SD rats housed in the Laboratory 
Animal Services Division of the Institute. Urine and plasma samples 
were stored in glass tube at -20°C until further use. All experiments 
were carried out in accordance with the guidelines of the local 
ethical committee.  
 
 
Chromatographic system  
 
An Agilent 1100 series LC system (Hewlett-Packard, USA) consisting 
of a G1311A Quaternary Pumps, a G1379A Degasser, a G1315B 
Diode-Array Detector and a G1313A auto sampler was employed in 
this research.  
The measurements of the Aconitum alkaloids were carried out on 
a ZORBAX Eclipse XDB-C18 column (150 mm × 4.6 mm i.d.; 5 µm 
particle size; Agilent Technologies Inc., USA) protected by an 
Eclipse XDB-C18 guard column (20 mm × 4.6 mm i.d.; 5 µm particle 
sizes) at 30°C. The solvents used for HPLC separation of the three 
alkaloids in samples were carried out with an acetonitrile (A) and 
buffer solution (B) containing 40 mmol/mL ammonium acetate 
adjusted with concentrated ammonia to pH 10.0 at a flow rate of 1.0 
mL/min. The gradient elution of the mobile phase was 15 - 60% (A) 
in 0 - 45 min and 60% (A) in 45 - 50 min. Detection was carried out 
at 240 nm with a reference wavelength of 380 nm.  
 
 
Preparation of standard and working solution  
 
The standard chemicals of three alkaloids were accurately weighed 
and dissolved with 0.05% hydrochloric acid (HCl) in methanol as 
stock standard solutions. These stock solutions were used for the 
preparation of a mixed working stock solution comprising aconitine 
(3210 µg/mL), mesaconitine (3060 µg/mL) and hypaconitine (3070 
µg/mL), which was prepared with 0.05% HCl in methanol. Analytical 
standards were prepared from mixed working stock solution by 
diluting it with reconstituted solution (0.05% HCl solution in 
methanol) over a concentration range of 1.605 - 160.5 µg/mL, 1.530 
- 153.0 µg/mL and 1.535 - 153.5 µg/mL for aconitine, mesaconitine 
and hypaconitine, respectively. All solutions were stored at 4°C and 
remained stable for at least one month (verified by reassaying the 
standard solutions).  
 
 
Preparation of urine and plasma standard solutions  
 
Urine and plasma standards were prepared from the mixed working 
stock solution by diluting with normal rat urine and plasma over a 
concentration range of 1.605 - 160.5 µg/mL, 1.530 - 153.0 µg/mL 
and 1.535 - 153.5 µg/mL for aconitine, mesaconitine and 
hypaconitine, respectively. Then, 0.5 mL of plasma standards and 
0.5 mL of urine standards were further spiked with 0.5 mL of 
acetonitrile; the supernatant was obtained by centrifugation (4°C, 
12000 rpm, 20 min), and was lyophilized with dry ice lyophilizer. The 
dry residue was dissolved in 1 mL of 0.05% HCl in  methanol.  All  









Figure 2. Effect of the pH values on the retention time of the 
three Aconitum alkaloids (A), and on the resolution of the 
adjacent peaks (B). B1: resolution of unknown compound and 
mesaconitine; B2: resolution of aconitine and hypaconitine;  




solutions were filtered through 0.45 µm filter membrane and 10µL 
filtrate was injected into the HPLC system for quantitation. 
 
 




Calibration curves were established based on six points for each 
alkaloid with concentrations of 1.605, 3.210, 8.025, 32.10, 80.25 and 
160.5 µg/mL for aconitine; 1.530, 3.060, 7.650, 30.60, 76.50 and 
153.0 µg/mL for mesaconitine and 1.535, 3.070, 7.675, 30.70, 76.75 
and 153.5µg/mL for hypaconitine. The prepared samples were 
processed in accordance with the preparation of urine and plasma 
standard solutions (as previously described) and were quantified in 





Precision was evaluated by HPLC analysis with a standard mixture 
solution of aconitine, meaconitine and hypaconitine under the 





tion and twice a day in three consecutive days  for  inter-day 





Six measurements were considered, one of the plasma standard 
solutions (the concentrations of aconitine, meaconitine and 
hypaconitine were 16.05, 15.30 and 15.35 µg/mL, respectively). The 
processing of the measurements was done in accordance with the 
preparation of urine and plasma standard solutions. The RSD within 




Recovery   
 
The three different concentration levels for aconitine (8.025, 32.10, 
80.25µg/mL), meaconitine (7.65, 30.6, 76.5 µg/mL) and 
hypaconitine (7.675, 30.70, 76.75 µg/mL) as low, medium and high 
concentration were used to assess the recovery of the assay 
method. The prepared samples above (n = 9) were then processed 
in accordance with the preparation of urine and plasma standard 
solutions and were quantified under the selected optimal conditions.  
 
 
RESULTS AND DISCUSSION  
 
Effect of pH value of the mobile phase buffer on the 
retention time and resolution of HPLC  
 
Mobile phase pH is an important factor in HPLC that can 
affect analytical results. The Aconitum alkaloids in the 
HPLC chromatograms displayed short retention time in 
the mobile phase with low- or mid-range pH; therefore, it 
was difficult to separate them from other alkaloids and 
from their metabolites. In this study, we employed an 
alternative method to separate the Aconitum alkaloids 
using a mobile phase pH that was above their pKa. Under 
such condition, they can exist in free-base forms because 
their cation charges were neutralized, which improved the 
peak shape. The retention times of aconitine, meaconitine 
and hypaconitine were compared with different pH values 
from 8.5 to 10.5 adjusted by concentrated ammonia solution, 
in which the ammonium acetate buffer concentration reached 
40mmoL/L. When the pH of the mobile phase was increased 
from 8.5, the retention time of aconitine, mesaconitine and 
hypaconitine increased (Figure 2A) because of the 
stronger interaction between these low-polar molecule 
and hydrophobic-bonded phase.   
The results of HPLC analysis showed that the pH values 
had a distinguished effect on the resolution of the three 
Aconitum alkaloids and other unknown compounds in the 
samples (Figure 2B). At a pH of 10.0, all these 
compounds were baseline, separated from each other 
with resolution values above 1.5. Allowing for the long 
elution time, the buffer solution for the present studies 
was finally chosen at a pH of 10.0.  
 
 
Effect of the mobile phase buffer concentration 
  
To decide an optimal concentration of  the  mobile  phase




















Aconitine 0.0073 - 0.73 Y = 912.57X + 
0.35 
0.972 Y = 940.97X + 
0.93 
0.974 
Mesaconitine 0.0077 - 0.77 Y = 888.72X + 
0.28 
0.969 Y = 966.69X + 
2.21 
0.963 
Hypaconitine 0.0075 - 0.75 Y = 943.90X + 
0.44 






buffer, four concentrations (10, 20, 30 and 40 mmoL/L) of 
the ammonia acetate buffer solution with pH 10.0 were 
used together with acetonitrile as the mobile phase for the 
HPLC analysis. The results indicated that the retention 
times of these three alkaloids decreased slightly with 
increasing concentrations of ammonia acetate in the 
buffer solution. Their resolutions were slightly affected by 
ammonia acetate concentration. Therefore, the 40 
mmoL/L buffer solution was selected as the HPLC mobile 
phase.   
 
 
Urine and plasma standards extraction conditions  
 
In order to optimize extraction conditions of urine and 
plasma standards, liquid-liquid extraction (LLE) and SPE 
were carried out. For LLE, two organic solvents (methanol 
and acetonitrile) were used as extraction solutions. The 
urine and plasma standards (0.5 mL) were extracted by 
methanol (1 mL) and acetonitrile (0.5 mL), respectively, in 
accordance with the preparation of urine and plasma 
standard solutions. For SPE, the urine and plasma 
standards (0.5 mL) were directly applied to oasis MCX 
cartridges (1 cc), which had been conditioned and equili- 
brated with methanol and deionized water. After washing 
the cartridges with 1 mL of 2% formic acid and 1 mL of 
methanol, successively, alkaloids were eluted with 1 mL 
of solution containing 5% ammonia in methanol. The 
eluate was lyophilized with dry ice lyophilizer; the residue 
was dissolved in 1 mL of 0.05% HCl in methanol. The 
results showed that acetonitrile and SPE are better for the 
extraction of alkaloids than methanol and LLE, respec- 
tively, because more alkaloids can be extracted with less 
volume solvents. The results of the recovery test also 
demonstrated that the extraction method was adequate 
for the analysis.  
 
 
Validation of HPLC assay  
 
A gradient elution program was developed to separate 
and quantify the three Aconitum alkaloids. Mesaconitine, 
aconitine and hypaconitine were successfully determined 
by a single run of HPLC and were eluted at 30.4, 36.9 and 
44.1min retention time, respectively. Aconitine, mesa- 
conitine and hypaconitine in plasma and urine standards 
were identified by comparing both their retention times 
and the UV spectra with those of reference standards. 
The peak purity was confirmed by studying the 
photodiode array detector (DAD) data with peaks of three 
alkaloids, in which no indication for impurities could be 
found.  
The linearity of the plot concentration (X, g) for each 
Aconitum alkaloids versus peak areas (Y, mAU) were 
investigated; the results are expressed as regression 
equations and their correlation coefficient (R) values are 
given in Table 1.   
The limit of detection, which was defined as the amount 
of the compounds required to produce a peak with a 
height three times the level of the average baseline noise 
(S/N = 3), was determined to be 2.64 ng for aconitine, 1.58 
ng for mesaconitine and 2.75 ng for hypaconitine.  
The analytical precision from the data of the intra-daily (six 
times per day) and inter-daily (twice a day for three 
consecutive days) determinations was indicated by the 
relative standard deviations, which were less than 10% for 
all three alkaloids.  
The RSDs of the repeatability test were less than 13% 
for all three alkaloids. The average recovery rates obtained 
were in the range of 85.63 - 90.94% for all with RSDs below 
14%. Therefore, these chromatographic systems for the 
quantitative determination of the three Aconitum alkaloids 
were appropriate for plasma and urine samples.  
 
 
Application of the HPLC method for plasma and urine 
samples  
 
The described method was applied to the analysis of a 
plasma sample and a urine sample from a male SD rat 
that had died of aconite root intoxication. As shown in 
Figure 3, the concentrations of mesaconitine and 
hypaconitine in plasma were 101 and 129 ng/mL; aconitine 
could not be detected because of very low levels. The con- 







Figure 3. HPLC chromatogram of rat plasma and urine samples: (a) Blank plasma sample; (b) plasma sample obtained from a rat 
which had died of aconite root intoxication; (c) blank urine sample; (d) urine sample obtained from a rat which had died of aconite 




tents of aconitine, mesaconitine and hypaconitine in urine 





Aconitum alkaloids poisoning was usually confirmed  by 
detecting highly toxic diester-diterpene of aconitine, 
mesaconitine and hypaconitine in rat plasma and urine. 
By selecting an appropriate alkaline buffer (40mmoL/L 
ammonium acetate buffers, pH 10.0) with acetonitrile as 
the mobile phase and suitable gradient elution program, 
satisfactory chromatographic separation of three Aconitum 
alkaloids with their symmetrical peaks  was  achieved. The  











effects of ammonium acetate buffer pH values and 
concentration on the chromatographic behavior of the 
three alkaloids were investigated. Method validation data 
indicate that the present method is a reliable, reproducible 
and accurate HPLC method for the simultaneous 
determination of the three Aconitum alkaloids in rat 





This study is founded by the TCM Special Project of MST 
of China: Study on quality control technology and quality 
evaluation with multi- indicators on Chinese herbs, fit for 





Ameri A (1998). The effects of Aconitum alkaloids on the central nervous 
system[J].Progress Neurabiol. pp: 211-234.  
Feng HT, Li SFY (2002). Determination of five toxic alkaloids in two 
common herbal medicines with capillary electrophoresis[J]. J. 
Chromatogr. A. 973:243-247. 
Feng HT, Yuan LL, Li SFY (2003). A nalysis of Chinese medicine 
preparations by capillary electrophoresis–mass spectrometry[J].J. 
Chromatogr. A. 1014:83-91.  
Guo ZS, Pan ZW, Chen XG, Hu ZD (2004). Analysis of the aconitine 
alkaloids in traditional Chinese medicines by nonaqueous capillary 
electrophoresis using a new recording mode[J]. Biomed. Chromatogr. 
18:381-387. 
Ito K, Tanaka S, Konno S, Konishi Y, Mizugaki M (1998). Report on the 
preparation of deuterium-labelled aconitine and mesaconitine and their 
application to the analysis of these alkaloids from body fluids as 
internal standard [J].J. Chromatogr. B. 714:197-203. 
Jiang ZH, Xie Y, Zhou H, Wang RJ, Liu ZQ, Wong YF, Cai X, Xu HX, Liu 
L (2005). Quantification of Aconitum alkaloids in aconite roots by a 
modified RP-HPLC method[J]. Phytochem. Anal. 16:415-421. 
Kaneko R, Hattori S, Furuta S, Hamajima M, Hirata Y, Watanashi K, 
Seno H, Ishii A (2006). Sensitive analysis of aconitine, hypaconitine, 
mesaconitine and jesaconitine in human body fluids and Aconitum 
tubers by LC/ESI-TOF-MS [J]. J. Mass Spectrom, 41:810–814. 
Li RJ, Gao XS (1991). Experimental studies on the absorption of 
aconitine in the upper digestive tract[J].China J. Chin. Mater. Med. 
16:46. 
Liu XX, Chao RB (2006). Determination of alkaloids in Radix Aconiti 
Lateralis Preparata by RP-ion-pair HPLC[J].Acta. Pharmaceutica. 
Sinica. 41:365-369. 
Ohta H, Seto Y, Tsunoda N (1997). Determination of aconitum alkaloids 
in blood and urine sample. High-performance liquid chromatographic 
separation,solid-phase extraction and mass spectrometric 
confirmation[J].J. Chromatogr. B. 69:351-356. 
Wang ZH, Guo DA, He Y, Hu CH, Zhang JZ (2004). Quantitative 
Determination of Aconitum Alkaloids in Blood and Urine Samples by 
High- performance Liquid Chromatography[J].Phytochem. Anal. 
15:16-20. 
Wang ZH, Wen J, Xing JB, He Y (2006). Quantitative determination of 
diterpenoid alkaloids in four species of Aconitum by HPLC[J].J. 
Pharm. Biomed. Anal. 40:1031-1034. 
Wang ZJ, He SJ, Xu SQ (2001). Determination of Aconitine alkaloids in 
Aconitum Plants and related proprietary medicines by liquid 
chromatography/mass spectrometry/mass spectrometry [J].Anal. 
Chem. 4:391-395. 
Zhang HG, Sun Y, Duan MY, Chen YJ, Zhong DF, Zhang HQ (2005). 
Separation and identification of Aconitum alkaloids and their 
metabolites in human urine[J]. Toxicol. 46:500–506. 
Zhou YP (1983). Pharmacological action and toxicity of Radix aconiti 
lateralia and its main components [J].Acta. pharmaceutica. sinica. 
18:394-400. 
 
 
 
 
 
